Current approved therapeutic strategies for IPF and LC treatment

Therapeutic modulation of V Set and Ig domain-containing 4 (VSIG4) signaling in immune and inflammatory diseases - Cytotherapy

Ivana CASTANIERE, Medical Doctor

Frontiers Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases

JCM, Free Full-Text

PDF) Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis

Exosomes derived from hypoxia-induced alveolar epithelial cells stimulate interstitial pulmonary fibrosis through a HOTAIRM1-dependent mechanism - Laboratory Investigation

Stefania CERRI, Assistant Professor, MD, PhD

Giorgia GUAITOLI, Resident

Anna SAMARELLI Università degli Studi di Modena e Reggio Emilia